Novel Compounds as NLRP3 Inhibitors for Treating Cardiovascular Diseases.

Published in: ACS medicinal chemistry letters (2024)

Provided herein are novel compounds as NLRP3 inhibitors, pharmaceutical compositions, use of such compounds in treating cardiovascular diseases, and processes for preparing such compounds.

Keyphrases

cardiovascular disease
type diabetes
cardiovascular risk factors
nlrp inflammasome
coronary artery disease